IL6 and diabetic kidney disease: It could also inhibit the expression of inflammatory factors IL-6, MCP-1, and ICAM-1 by reducing oxidative stress and inhibit phosphorylation of NF-kB p65 both in DKD rat models and mesangial cells stimulated by high glucose [34].